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Abstract
Background: Despite the availability of effective antibiotic therapies, pneumococcal meningitis (PM) has a case
fatality rate of up to 30% and causes neurological sequelae in up to half of the surviving patients. The underlying
brain damage includes apoptosis of neurons in the hippocampus and necrosis in the cortex. Therapeutic options
to reduce acute injury and to improve outcome from PM are severely limited.
With the aim to develop new therapies a number of pharmacologic interventions have been evaluated. However,
the often unpredictable outcome of interventional studies suggests that the current concept of the pathophysiolo-
gic events during bacterial meningitis is fragmentary. The aim of this work is to describe the transcriptomic
changes underlying the complex mechanisms of the host response to pneumococcal meningitis in a temporal and
spatial context using a well characterized infant rat model.
Methods: Eleven days old nursing Wistar rats were infected by direct intracisternal injection of 2 × 10
6cfu/ml of
Streptococcus pneumoniae. Animals were sacrificed at 1, 3, 10 and 26 days after infection, the brain harvested and
the cortex and hippocampus were sampled. The first two time points represent the acute and sub-acute phase of
bacterial meningitis, whereas the latter represent the recovery phase of the disease.
Results: The major events in the regulation of the host response on a transcriptional level occur within the first 3
days after infection. Beyond this time, no differences in global gene expression in infected and control animals
were detectable by microarray analysis. Whereas in the acute phase of the disease immunoregulatory processes
prevail in the hippocampus and the cortex, we observed a strong activation of neurogenic processes in the
hippocampal dentate gyrus, both by gene expression and immunohistology starting as early as 3 days after
infection.
Conclusions: Here we describe the cellular pathways involved in the host response to experimental pneumococcal
meningitis in specified disease states and brain regions. With these results we hope to provide the scientific basis
for the development of new treatment strategies which take the temporal aspects of the disease into account.
Background
Bacterial meningitis (BM) is associated with a mortality
rate of up to 30% and up to 50% of the surviving
patients suffer from permanent neurological sequelae
which include deafness, learning impairment, seizure
disorders and cerebral palsy [1-3]. The most common
etiological agent of non epidemic BM is Streptococcus
pneumoniae (pneumococcus) [4]. Among the different
forms of bacterial meningitis, pneumococcal meningitis
is associated with the highest case fatality rate and inci-
dence of neurological sequelae [1,5,6]. Morbidity and
mortality have largely remained unchanged over the last
decades in spite of advances in antimicrobial and inten-
sive care therapies [7]. Therapeutic options to reduce
a c u t ei n j u r ya n dt oi m p r o v er e c o v e r yf r o mB Ma r el i m -
ited [8]. In BM, the only clinically used, adjunctive ther-
apy is the administration of dexamethasone during the
acute disease phase [2,8]. While this leads to improve-
ment primarily on mortality in adult patients, there is
currently no conclusive evidence that the drug is
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any medium, provided the original work is properly cited.beneficial in paediatric patients [2,8,9]. Given the limited
success in reducing brain damage during the acute dis-
ease, it appears imperative to expand the scope of stra-
tegies from the acute disease phase into the recovery
phase with the aim to improve the outcome of brain
injury. Thus, current therapies for BM are insufficient
and new approaches to the adjunctive therapy of BM
are needed. Understanding the processes of brain
damage and repair following BM is a prerequisite for
the development of new drugs that can preserve and
restore neuronal function.
The aim of this work is to describe the transcriptomic
changes underlying the complex mechanisms of the
host response to pneumococcal meningitis in a temporal
and spatial context. For this purpose we evaluated the
gene expression profile of the two brain structures pre-
dominantly affected by brain damage, i.e. the cortex and
the hippocampus, at four different stages of the disease
in an infant rat model.
The continuously growing pool of biological metadata
provides the possibility to shift the interpretation of
transcriptomic data from a “gene by gene” approach to
a more biological system-based analysis. In the present
work we describe the transcriptomic data under two
aspects: the categorization of regulated genes based on
the defined and organism independent vocabularies of
the Gene Ontology Database [10] and the Kyoto Ency-
clopedia of Genes and Genomes (KEGG) pathway data-
base [11-13] a collection of graphical cellular pathway
informations. Due to the complexity of the samples in
regard to the different cell types within a given brain
structure, association of transcriptional data with histo-
morphological findings is helpful in validating the find-
ings. Therefore we assessed the presence and tissue
distribution of two pathogenetically relevant cell types
namely the microglia and proliferating neuronal stem/
progenitor cells. The microglia plays a major role in the
initiation and coordination of the innate immune
response of the acute disease phase [14-18]. Microglia
adopt an amoeboid phenotype and a phagocytic- and
antigen-presenting-cell-type-function during the later
phase [14-16,19]. The proliferation, differentiation and
functional integration of neuronal stem/progenitor cells
are a prerequisite for the repair of damaged tissue and
the re-establishment of neurofunctional integrity. In this
work we identified regulative pathways that influence
tissue homeostasis in the different stages of the disease
and which may provide new therapeutic targets for the
reduction of neuronal sequelae.
Methods
Model of experimental bacterial meningitis
We used an established model of experimental pneumo-
coccal meningitis in infant rats [20]. All animal studies
were approved by the Animal Care and Experimentation
Committee of the Canton of Bern, Switzerland, and fol-
lowed the Ethical Principles and Guidelines for Experi-
ments on Animals by the Federal Veterinary Office of
Switzerland. On postnatal day 11, nursing Wistar rats
(Charles River, Germany) were infected by direct intra-
cisternal injection of 10 μl saline solution, containing
2×1 0
6 cfu/ml of Streptococcus pneumoniae (serogroup
3), with a 32 gauge needle. Sham-infected animals were
injected with 10 μl of sterile pyrogen free saline solu-
tion. Eighteen hours after infection and at predeter-
mined later time points, animals were weighted and
clinically assessed using the following scale of scores:
1 = coma; 2 = does not turn upright after being placed
on the back; 3 = turns upright within 30 s; 4 = minimal
ambulatory activity, turns upright in less than 5 s; 5 =
normal [20]. Animals with a score of 2 or below were
immediately sacrificed for ethical reasons. Cerebrospinal
fluid (CSF) was obtained by puncture of the cisterna
magna and 5 μl were cultured quantitatively on agar
plates in order to document successful infection. At the
same time point antibiotic treatment of the infected ani-
mals with 100 mg/kg ceftriaxone (Roche Pharma, Rein-
ach, Switzerland) subcutaneously (s.c.) was initiated.
Cisternal puncture for CSF sampling was repeated at 1
and 3 days post infection. After withdrawal, CSF sam-
ples were immediately centrifuged for 10 min/4°C/
13’000 rpm (10’000 g) and the supernatant was frozen
at -80°C and stored for further analysis.
Study design
Animals were sacrificed by an overdose of intraperito-
neal (i.p) pentobarbital (100 mg/kg Abbot Laboratories,
Chicago, USA) at the predefined time points e.g. 1 day,
3 days, 10 days and 26 days after infection. The first
two time points represent the acute and the subacute
disease-phase of bacterial meningitis respectively,
whereas the latter two timepoints represent the recov-
ery phase of the disease. At each time point 6 infected
and 6 sham infected animals were sacrificed. Control
and infected animals were age matched to avoid differ-
ences in the gene expression patterns due to develop-
mental processes in the infant rat brain. Animals were
perfused via the left cardiac ventricle with 30 ml of
RNAse-free ice-cold phosphate-buffered saline (PBS).
Immediately after brain removal, the meninges were
removed and the brain was divided into the two hemi-
spheres. From the left hemisphere the cortex and the
hippocampus were dissected, transferred into RNAla-
ter® (Applied Biosystems/Ambion, Rotkreuz, Switzer-
land) and stored at 4°C until subsequent RNA
extraction; the right hemisphere was fixed in parafor-
maldehyde (PFA) 4% in PBS for the subsequent histo-
pathological assessment of brain injury.
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To assess the effect of bacterial meningitis on brain
damage, the brains were evaluated histomorphologi-
cally. After sacrifice, animals were perfused with phos-
phate buffered saline (PBS), brains were removed and
postfixed in PFA 4% in PBS overnight at 4°C. Subse-
quently the brain tissue was dehydrated in ascending
alcohol and embedded in paraffin. From each brain
four 10 μm sections of the dentate gyrus were cut and
mounted on a glass slide and stained with cresyl violet
(Nissl stain). Neurons in the dentate granule layer of
the hippocampus with a nuclear morphology typical
for apoptosis (condensed, fragmented nuclei and/or
apoptotic bodies) were counted in 3 visual fields (mag-
nification, × 400) in each of the 4 blades of the dentate
gyrus applying the following scoring system: 0-5 cells =
0; 6-20 cells = 1 and >20 cells = 2. This scoring system
has been previously validated by other methods of
apoptosis detection including active caspase-3 and
TUNEL staining [21].
Immunohistochemistry
For microglia staining, 10 μm cryo-sections were
mounted on chrom alum/gelatine-coated slides and
incubated overnight with a monoclonal mouse anti-AIF-
1 antibody (Iba-1, Wako Pure Chemical Industries, Ltd.)
or with a monoclonal mouse anti-rat CD68 antibody
(AbD Serotec GmbH, Düsseldorf; Germany). A goat
anti-mouse IgG Cy3-conjugated antibody (Jackson
ImmunoResearch Laboratories, West Grove, PA) was
used as secondary antibody. The slides were mounted
with Mowiol® (Merck, Darmstadt, Germany) containing
2.5% Dabco® (Sigma) and photographed with an Axio-
phot fluorescence microscope equipped with a digital
camera.
Bromodeoxyuridine labeling and histomorphometry
To document cell proliferation from the acute phase
of the disease into the late phase, infant rats received
50 mg/kg BrdU (Sigma) at day 1 to 3 after infection.
BrdU is a thymidine analog which incorporates into
newly synthesized DNA [22,23].
Six micrometers thick brain sections were stained for
incorporated BrdU (anti-BrdU, Dako Schweiz AG, Baar,
Switzerland) and counterstained with 4’,6-Diamidin-2’-
phenylindol- dihydrochlorid (DAPI). For cell density
counting, digitized images, acquired using a conven-
tional microscope and a charge-coupled device camera,
were used. Using ImageJ software (NIH), regions of
interest were outlined in the dentate gyrus, using the
DAPI-stained image and superimposed on the BrdU
image. After calibration, the surface areas were deter-
mined and a cell proliferation determined as the number
of BrdU positive cells/unit area [22].
RNA processing, quality control and chip hybridization
Tissue samples of the cortex and the hippocampus
from the 12 control and from the 12 infected animals
were processed and analyzed separately; thus in total
48 arrays were hybridized. Total RNA was extracted
from brain samples using RNeasy® Lipid Tissue kit
(QIAGEN, Basel, Switzerland) and purified with
RNeasy columns (QIAGEN, Basel, Switzerland). Quan-
tification and assessment of RNA integrity were per-
formed on the Agilent 2100 bioanalyzer platform
(RNA 6000 Nano, Agilent technologies, Waldbronn,
Germany) and validated on the NanoDrop® (Nano-
Drop, Wilmington, USA) quantification device. Based
on RNA quality control results and histopathological
evaluation of hippocampal damage (apoptosis score)
RNA extracts from 3 infected and 3 control animals
were selected for each time point for array hybridiza-
tion. Double-stranded cDNAs were synthesized from
5 μg of total RNA using an oligo dT-T7 promoter pri-
mer (Roche Molecular Biochemicals, Mannheim, Ger-
many). The cDNAs obtained were used as templates
for in vitro transcription using the Megascript kit pur-
chased from Ambion (Austin, TX) and biotinylated
nucleotides (Bio-11-CTP and Bio-16-UTP) provided by
Roche Molecular Biochemicals (Basel, Switzerland).
Fragmented in vitro transcripts (cRNAs) were hybri-
dized overnight onto commercially available rat micro-
arrays (GeneChip® Rat Genome 230 2.0 Array,
Affymetrix, Santa Clara, CA) containing 31’000 probe
sets representing approximately 28’000 well-substan-
tiated rat genes. The hybridized samples were stained
with streptavidin-R phycoerythrin (SAPE, Molecular
Probes Inc., Eugene, OR) and the signal was amplified
using a biotinylated goat anti-streptavidin antibody
(Vector Laboratories, Burlingame, CA). Washing, stain-
ing and amplification were carried out in an Affyme-
trix GeneChip® Fluidics Station 450. Microarrays were
scanned in an Affymetrix GeneChip® scanner 3000.
Signal intensities were calculated based on image files
with the Affymetrix GeneChip® Operating software
(GCOS) v1.1.1. Array data was deposited and is
curated at the ArrayExpress platform http://www.ebi.
ac.uk/microarray-as/ae/. The accession number is
E-MEXP-1656.
Datamining
Chip data analysis was performed on the R platform for
statistical programming using packages of the Biocon-
ductor project [24]. Due to the asymmetric distribution
of microarray data all datasets were log2 transformed.
Background correction, normalization and data sum-
mary were performed with non linear methods using
the rma function of the affy package [25]. Chip quality
assessment was exploratively performed based on
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visualizing signal intensity dependent effects on the log-
ratios. Additionally the quality of the hybridized cRNA
was assessed by RNA digestion plots where the mean
intensities of all probes on an array are plotted accord-
ing to their 5’ to 3’probeset position (affy package).
To reduce the number of hypotheses to be tested in
the subsequent significance tests, gene filtering was per-
formed. All genes that were expressed under the esti-
mated background intensity of 60 fluorescent units (FU)
on at least 3 of the 48 chips and genes showing an
interquarantile range (IRQ) of less than 0.5 were
excluded from significance testing.
Significance testing was performed using the limma
package [26,27]. Type 1 error was corrected by the Ben-
jamini-Hochberg false discovery rate algorithm [28].
Gene ontology (GO) statistics was calculated with the
GOstats package [29]. For each time point the according
significantly regulated genes were associated to the bio-
logical process specific GO identifier. The representation
of a given GO identifier in the population of the signifi-
cant regulated genes was compared to the abundance of
the same GO identifier in the total brain transcriptome.
To test if a given GO identifier is significantly more
abundant in the population of regulated genes a hyper
geometric distribution was used to calculate p-values.
This approach allows bringing a selected group of tran-
scripts in a biological context by following the trace of
significantly over-represented GO terms throughout the
GO structure.
Correspondence Analysis (COA) was carried out with
the made4 [30] package which provides several algo-
rithms for multivariate microarray data analysis. An
overview of the data mining workflow is provided in
Figure 1.
Data Dimension Reduction: Correspondence Analysis
(COA)
The aim of the diverse dimension reduction methods
is, as the name implies, to reduce the essence of the
interrelation of multidimensional data to a lower com-
plexity. This reduction to few transformed variables
allows the graphical interpretation of complex data in
the two or three dimensional space. In contrast to
principal component analysis (PCA) which is used for
the exploratory description of linear trends in data
(eigenanalysis of a covariance matrix), COA analyses
the association between microarray samples and genes
with a 2 way contingency table based chi-square statis-
tics (eigenanalysis of a chi-square distance matrix). It
has been shown, that compared to PCA, COA is less
vulnerable to unimodal or non-linear trends which are
often present in biological data. In our study COA
analysis was performed on the median expression
values of each experimental group.
PCR
The SuperScript™ II First Strand cDNA Synthesis Sys-
tem (Invitrogen, Basel, Switzerland) was used with 5 μg
total RNA and 250 ng random hexamer primers (Pro-
mega, Madison, WI), following the manufacturer’sp r o -
tocol. To minimize methodological effects interfering
with cDNA quantification all total RNA samples were
processed in parallel. The cDNA samples (CX 1.6 μg/μl;
HC 1.1 μg/μl) were diluted 1 to 5 with RNAse-free H2O
and aliquots (CX 0.3 μg/μl; HC 0.2 μg/μl) were stored at
-20°C, respectively at -80°C. Template cDNA was ampli-
fied using the ABIPrism 7700 Sequence Detection sys-
tem (Applied Biosystems, Foster, CA). For TGF-b1,
Aquaporin 4 and Folate Receptor 2 amplification detec-
tion the SYBR-green PCR Master Mix (Qiagen, Basel,
Switzerland) was used. The specificity of the SYBER-
green signal was validated by the presence of a single
sharply defined melting peak for every PCR run. The
amount of template used for the PCR reaction was nor-
malized to the commonly used housekeeper gene Gly-
ceraldehyde-3-phosphate dehydrogenase (GAPDH).
GAPDH quantification was performed with the Taq-
Man® rodent GAPDH control reagents from Applied
Biosystems (Foster City, CA) containing a VIC™ labeled
GAPDH probe (excitation at 554 nm) and a forward
and reverse primer set.
Oligonucleotide primers used in this study were
designed with Primer Express™ software Version 2.0
(Applied Biosystems, Foster City, CA) and were supplied
by Microsynth laboratories (Balgach, Switzerland). Pri-
mer sequences and GenBank association numbers are
listed in table 1.
Luminex
The commercially available Rat 9-Plex cytokine panel A
from BIO-RAD was used (BIO-RAD, Hercules, CA, kit#
171-K11070) to assess the protein levels of IL-1a/b,I L -
2, IL-4, IL-6, IL-10, GM-CSF, IFNg and TNFa with the
Luminex® xMAP™ technology. CSF samples were centri-
fuged and the supernatants were diluted 1:5 in Bio-Plex
r a ts e r u ms a m p l ed i l u e n ta n dm i x e dw i t ha n t i b o d y -
coated microspheres on a membrane microtiter plate. In
the 9-plex kit, nine different microspheres with a speci-
fic spectral signature are included, each coated with an
antibody specific for one cytokine. The bound cytokines
were detected with a secondary antibody labeled with
biotin. Signal was enhanced by a streptavidin/phycoery-
thrin complex. Flow cytometry and signal detection was
performed by Bio-Plex™ 200 system and raw data were
analyzed with Bio-Plex Manager 4.1 software.
Wittwer et al. BMC Infectious Diseases 2010, 10:176
http://www.biomedcentral.com/1471-2334/10/176
Page 4 of 21Statistical analysis of protein concentration data was
done with GraphPad prism version 4.0 (GraphPad Soft-
ware Inc., San Diego, CA) by 1 way ANOVA. Pair wise
group comparison was calculated by Tukey’s multiple
comparison test.
Protein quantification was performed using the colori-
metric BCA Protein assay kit (Pierce, Rockford, IL).
Quantification of the samples was based on a BSA
calibration curve with ascending concentrations from
0 μg/ml to 2 μg/ml.
Results
Clinical parameters of meningitis
All rats infected with S.pneumoniae developed meningi-
t i sa sd o c u m e n t e db yp o s i t i v e bacterial CSF cultures
(log10 6.8 - log10 8.0 cfu/ml) at 18 h after infection,
Figure 1 Data Analysis Flowchart. Figure 1: Overview of the data analysis strategy chosen for the present work. The numbers in the boxes
indicate the size of the gene pool. Oval boxes describe the used data analysis/reduction strategies. The vertical dashed lines indicate the
stepwise reduction of the gene set according to the available information of the metadata resources. The horizontal dashed lines indicate the
reduction of the gene set based on statistical analysis.
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to uninfected animals (table 2) . Sham-infected animals
(n = 24) did not show clinical signs of disease.
Apoptotic cells in the dentate gyrus
As reported previously, infection with S.pneumoniae
causes apoptosis in the subgranular zone of the hippo-
campal dentate gyrus [20,31,32]. During the acute dis-
ease (1 day after infection) the median score of
apoptotic neurons was 1.66. In the late acute phase of
disease (3 days after infection) the number of apoptotic
cells decreases to control levels [21]. In animals
assessed 10 days and 26 days after infection, no apop-
totic damage was detectable in the dentate gyrus.
Apoptosis was exclusively localized to the subgranular
zone of the hippocampal dentate gyrus. This observa-
tion is in agreement with previous findings that imma-
ture neurons in the subgranular zone are most prone
to apoptosis [22].
Inflammatory parameters
Nine different cyto-/chemokines were assessed on the
protein level in CSF samples collected at 1 day after
infection. The pro- inflammatory cytokines IFN-g,
TNF-a,I L - 1 a,I L - 1 b, IL-6 and IL-10 showed a signifi-
cant up-regulation in infected animals compared to
sham-infected animals. Levels of GM-CSF, IL-4 and
IL-2 were not significantly altered in infected vs.
sham-infected animals (table 3). Non-parametric spear-
man correlation of protein concentration ratios with
the according gene expression ratios was highly signifi-
cant (rs = 0.83; p = 0.0052).
PCR
To validate the microarray data the expression levels of
3 genes were assessed by real-time PCR. Chip sensitivity
and signal linearity were estimated by selecting a set of
genes which spans an expression range from 60 FU
(background level) to 8000 FU.
Gene regulation was assessed for the low abundant
Folic acid receptor, the high abundant Aquaporin 4
water channel and the intermediately expressed growth
factor TGF-b1. The highest discrepancy in expression
ratios between PCR and GeneChip quantification was
seen for the low abundance transcript coding for the
Folic acid receptor. This is most likely due to the low
expression value of this transcript in the control animals
which lies below the background level. Thus the lack of
accurate expression estimates for the controls hampers
the calculation of an expression ratio. This notion holds
true for all transcripts with a below-background-expres-
sion in a given treatment group. Expression ratio calcu-
lations for intermediate and high abundance genes were
similar in both methods.
The Pearson correlation of infected vs. control ratios
between RT-PCR and GeneChip data was r = 0.998
(table 1).
Microarrays
From totally 31’000 probe sets of the rat genome repre-
sented on the chip, about 17’000 were expressed over
background level. Of these expressed probes a subgroup
of 11’000 transcripts showed a substantial signal varia-
tion (IQR of >0.5) and thus were included in subsequent
hypothesis testing. After statistical analysis 8699 probes
were found to be significantly regulated in infected ani-
mals compared to sham-infected controls over all of the
investigated time points and tissues.
An Entrez ID could be assigned to 5609 individual
genes which were included in the subsequent gene
annotation based statistical analysis (see Figure 1 for an
overview of the data mining workflow).
Spatial and Temporal Gene Expression
In the cortex the peak of transcriptomic regulation in
regard to the number of transcripts which are
Table 1 PCR Primers and Results
Name Forward Reverse Ratio Array Ratio PCR
Folate receptor 2
(XM_215013)
GATTGCCCTGGGTTGAGTCA TCACTCCTACAAGGTCAGCAACTATAG 41.7 22.3
Aquaporin 4
(NM_012825)
GCTTTCTTCTCCCAAGCACAA TCTTGCTGCCACAGACACAAA 5.8 2.6
TGF-b (NM_021578) GGAAGGGTCGGTTCATGTCA CGTGGAAATCAATGGGATCAG 2.5 2.2
Primers used for the assessment of the expression level of the low abundant Folic acid receptor, the high abundant Aquaporin 4 water channel and the
intermediately expressed growth factor TGF-b1.
Table 2 Clinical Parameters
Clinical parameters
Time Status Weight Clinical score Apoptosis score
1 day Control 27.6 (100%) 5 0
Infected 23.81 (86%) 3 1.66
3 days Control 34.5 (100%) 5 -
Infected 24.1 (69.8%) 4 -
10 days Control 54.2 (100%) 5 -
Infected 44.9 (82.2%) 5 -
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tion (2974 transcripts). At 3 days after infection the
number decreased by ~ 32% (1892). At 10 days after
infection only 11 transcripts were found to be regulated
(Figure 2A). At 26 days after infection there was no
detectable difference between the gene expression pro-
files of infected and control animals.
In contrast to the cortex the peak of transcriptional
regulation in the hippocampus was observed at 3 days
after infection (5205 transcripts) with an increase of
32% compared to the acute phase at 1 day after infec-
tion of the disease (3246 transcripts). In accordance to
the findings in the cortex the number of regulated
transcripts drops to 11 at 10 days and 0 at 26 days
after infection (Figure 2A). Assessment of the propor-
tion of genes concomitantly regulated in both tissues
at a given time point showed, that at 1 day after infec-
tion the hippocampus and the cortex share ~67%
Table 3 Luminex Results
Cytokines [pg/ml]
IFNgamma TNFalpha IL-1alpha IL-1beta IL-6 IL-10 GMCSF IL-4 IL-2
Control 141 401 38 170 142 108 172 83 452
Infected 5833 4418 623 11611 47199 2192 145 68 623
Ratio [inf/cont] 41.4 11.0 16.4 68.3 332.4 20.3 0.8 0.8 1.4
Assessment of 9 different chemo-/cytokines in the CSF of infected and uninfected rats 1 day post infection.
Figure 2 Venn Diagrams.S c h e m a t i co ft h es p a t i a la n dt e m p o r a lg e n ee x p r e s s i o ni nt h ee x p e r i m e n t a lg r o u p s .T h en u m b e r si nt h ec i r c l e s
represent the number of transcripts which are significantly up- or down-regulated in a given condition. A) Comparison of the extent of
transcriptional regulation within the cortex and the hippocampus in relation to the time after infection. In contrast to the cortex which shows
the highest number of regulated genes at 1 day after infection, the transcriptional regulation in the hippocampus peaks 3 days after infection.
B) In the early acute phase of the disease at 1 day after infection, the hippocampus and the cortex share ~60% of the significantly regulated
transcripts. At 3 days after infection, in the late acute phase, the number of co-regulated genes drops to 50% for the cortex and 18% for the
hippocampus.
Wittwer et al. BMC Infectious Diseases 2010, 10:176
http://www.biomedcentral.com/1471-2334/10/176
Page 7 of 21(1925 transcripts) of the regulated genes. At 3 days
after infection the proportion of shared genes dropped
to 52% in the cortex and 22% in the hippocampus (927
transcripts) (Figure 2B).
Correspondence Analysis (COA)
Based on the Eigenvalues, which are a measure for the
amount of data variance an Eigenvector describes, the 3
most informative components of the data can be
defined. The 1st component (F1) which explains most of
the variance in the data set (highest Eigenvalue) is the
axis separating the non-infected controls from the
infected animals. The second component (F2) separates
the phases of the disease (1 day after infection/3 days
after infection) and the third component (F3) discrimi-
nates between the investigated brain structures (cortex/
hippocampus) (Figure 3 A/B). The identification of our
experimental parameters (infection, time, tissue) with an
unsupervised dimension reduction method confirms the
validity of our dataset in regard to extract information
about transcriptional regulation specific for a given
experimental condition.
GO statistics
The assessment of the gene expression profile in two
differently affected brain structures at different time
points allows extracting subpopulations of regulated
genes which give insight into spatial and temporal
mechanisms of the disease. In the presented study, sta-
tistics for the over-representation of biological processes
was carried out for every tissue and time specific gene
set, as well as for the intersection of all experimental
endpoints.
Genexpression in the hippocampus at 1 day after
infection
From the 433 individual genes that were found to be
significantly regulated in the hippocampus at 1 day after
infection the most generic GO terms found to be signifi-
cantly over-represented were cell differentiation
(GO:0030154) and cell development (GO:0048731).
Following the track of over-represented terms
throughout the GO structure leads to processes involved
in neuron generation and differentiation. Strikingly, the
proportion of down-regulated genes is higher in all of
the significantly over-represented processes providing
evidence, that cellular development and differentiation is
generally down-regulated in the hippocampus 1 day
after infection (Figure 4). Analyzing the genes involved
in neurogenic processes on a cellular pathway level
shows, that key components of bone morphogenic pro-
teins (BMPs) signaling are up-regulated (BMP2, Smad1,
p300, STAT3, ID1). BMPs are members of the TGF-b
family and are involved in the inhibition of neurogenesis
by the induction of inhibitors of differentiation and
DNA binding (IDs). The cellular components where
these processes take place are the membrane, extracellu-
lar space and the proteinaceous extracellular matrix.
Genexpression in the hippocampus at 3 days after
infection
The GO graph for the visualization of the biological
processes in the hippocampus at 3 days after infection is
similar to the one at 1 day after infection due to the
similarity of most of the significantly over-represented
GO terms. The processes of nervous tissue development
lead to processes of neuronal remodelling as there are
Figure 3 COA analysis. Correspondence Analysis based on the mean expression values (n = 3) of all genes that are expressed over background
level in a given experimental group. Each experimental group is represented by a coloured globe. The 3 components with the highest
explanatory value are visualized in two planes of projection: A [F1: health state, F2: time after infection] and B [F1: infection state, F3: tissue type].
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lation of axonogenesis (GO:0050770), filopodium forma-
tion (GO:0046847) and synapse organization and
biogenesis (GO:0050808). In contrast to 1 day after
infection, the majority of the genes involved in these
processes are up-regulated (Figure 5).
T h ea s s i g n m e n to ft h et r a n s c r i p t sf o u n dt ob e
involved in neurogenic processes to KEGG biological
pathways reveals, that a substantial number of genes are
involved in the pro-neurogenic wnt and TGF-b signal-
ling pathways (Figure 6, Figure 7). With a focus on the
wnt signalling pathway we found an up-regulation of
Figure 4 GO graph hippocampus 1 day post infection. GO graph induced by the biological processes which are over-represented in the
gene set of the hippocampus at 1 day post infection. Specificity of the biological processes inclines from bottom to top of the graph.
Compared to the totality of genes which are expressed in the hippocampus at 1 day after infection, the GO terms written in red are significantly
over-represented in the collective of the significantly regulated genes in the hippocampus at 1 day after infection. Blue sections in pie charts
illustrate the proportion of significantly down-regulated genes, red sections stand for significantly up-regulated genes. Strikingly, in all of the GO
terms involved in developmental processes in general the significantly down-regulated genes are predominant.
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Page 9 of 21several genes involved in the canonical as well as non-
canonical branch. For the canonical branch we found an
up-regulation of components of the scaffolding complex
which governs the phosphorylation and subsequent
degradation of b-catenin. Wif-1, an inhibitor of the
canonical wnt pathway was down-regulated and pro-
vides further evidence for pathway activation. The up-
regulation of the wnt ligand wnt5a and the calcium
binding protein p22 (CHP) indicates an activation of the
non-canonical Wnt/Ca2+ branch.
Transcripts coding for the transforming growth factor
beta 1 (TGF-b1) and its receptor TGF-b Receptor 1 as
well as those coding for the receptor regulated R-Smads
2a n d3a n dt h eC oS m a d4w e r ef o u n dt ob e
Figure 5 GO graph hippocampus 3 days post infection. GO graph induced by the biological processes which are over-represented in the
gene set of the hippocampus at 3 days after infection. Specificity of the biological processes inclines from bottom to top of the graph. GO
terms written in red are significantly over-represented in the significantly regulated gene set. The same GO terms describing neurogenic
processes are over-represented as at 1 day after infection. Blue sections in pie charts illustrate the proportion of significantly down-regulated
genes, red sections stand for significantly up-regulated genes. In contrast to 1 day post infection GO terms involved in developmental processes
are represented mainly by significantly up-regulated genes
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Page 10 of 21up-regulated. In contrast to the acute phase of the dis-
ease (1 day after infection) the expression of transcripts
involved in the anti-neurogenic BMP signalling pathway
returned to control levels. Furthermore the expression
of ID1 was significantly down-regulated. In parallel to
the activation of pro-neurogenic pathways a significant
increase in the rate of cell proliferation was observed in
the dentate gyrus during the later phase of the disease
(1-3 days after infection) compared to non infected con-
trol animals in the model used for the current study
(infected:405 ± 25 BrdU cells/mm
2 ,n=4v sn o n -
infected:307 ± 51 BrdU cells/mm
2, n = 5; unpaired t test
p < 0.001) and in other models of pneumococcal menin-
gitis [23,33].
Figure 6 Wnt signalling pathway. Clustering of experimental groups based on significantly regulated genes of the wnt signalling pathway.
Up-regulated [red] unchanged [green] down-regulated [blue]
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Page 11 of 21Genexpression in the cortex at 1 day after infection
In the cortex 378 annotated genes with a unique Entrez
ID were found to be significantly regulated at 1 day
after infection. In comparison to the other gene sets
there were few and rather unspecific biological processes
over-represented. Furthermore the analysis of the con-
structed GO graph reveals that the identified processes
are solely connected through very generic parent terms.
These findings imply that besides the processes of
inflammation and immune response affecting both tis-
sues at 1 day after infection there are no distinct disease
mechanisms in progress in the cortical tissue at this
early stage of the disease.
Genexpression in the cortex at 3 days after infection
At 3 days after infection 421 individual annotated genes
were found to be significantly expressed in the cortical
tissue. The biological process cell communication
(GO:0007154) was the most general GO term found to
be significantly over-represented. The branches deriving
from this term are ending in nodes involved in
neurotransmitter transport, -signalling and -secretion
(GO:0006836, GO:0007218, GO:0007269) as well as in
processes of synaptic transmission (GO:0007268,
GO:0035249, GO:0019226). As to be expected these
p r o c e s s e sm a i n l yt a k ep l a c ei nt h ep l a s m am e m b r a n e
(synapse, dendrite, lammelopodium, growth cone) and
vesicular system (clathrin coated vesicles) of the cells.
Concerning the molecular function most of the genes
fall into the categories of calcium ion binding, gated
channel activity and transmembrane receptor activity.
Time and tissue Intersection
The 322 individual genes which were significantly regu-
lated at both 1 day after infection and 3 days after infec-
tion are mainly involved in processes of the immune-
and inflammatory response.
The not antigen specific innate immune response is
the first line of host defence against an invading patho-
gen. In accordance with the published literature [34] we
found, that the Toll like receptor (TLR) signalling path-
way is a predominant mechanism in PM for the
Figure 7 TGF beta signalling pathway. Clustering of experimental groups based on significantly regulated genes of the TGF-beta signalling
pathway. Up-regulated [red] unchanged [green] down-regulated [blue]
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Page 12 of 21initiation of inflammatory and immune genes. Tran-
scripts coding for the pattern recognition receptors
TLR2 and CD14 (mCD14), the adaptor protein MyD88
[17,35] and the nuclear factors I-kappaB and NF-kappaB
as well as p38 and AP-1 were found to be up-regulated
at both time points.
The transcripts coding for the heterodimer S100A8/
S100A9 which are members of the damage-associated
molecular pattern (DAMP) molecules show the highest
expression value in infected animals of all transcripts
detected on the chip. Upon stress S100A8/S100A9 are
released into the extracellular compartment by damaged
cells or macrophages and act as danger signals activating
immune cells and vascular endothelium. As a conse-
quence of the activation of the above described path-
ways, we found an up-regulation of mRNAs coding for
cytokines, chemokines and their receptors as well as for
components of the complement system.
Transcripts coding for proteins involved in the com-
plement classical pathway (C1q, C1r, C1s, SERPING1),
the lectin pathway (MASP1/2) and the alternative path-
way (C3, HF1, BF) were found to be highly up-regulated.
Concomitantly to the activation of immune and
inflammatory pathways, the microglia specific allograft
inflammatory factor 1 (AIF-1) was significantly up-regu-
lated at 1 day after infection with a peak at 3 days after
infection This regulation kinetics is in well accordance
to the immunohistochemical detection of AIF-1, show-
ing the distribution of microglia in brain tissue at 1 day
after infection and 3 days after infection (Figure 8). A
similar expression profile is observed for the macro-
phage specific marker CD68, which shows a pronounced
up-regulation at 3 days after infection and is a correla-
tive for the differentiation of microglia into mature
macrophages. A morphological sign for microglia differ-
entiation is the transformation from a ramified into a
rod shaped and amoeboid form (Figure 8). Besides of
these data confirming the histological findings, we found
several transcripts which are involved in the orchestra-
tion of the microglial response to infection (Figure 9).
Discussion
The evaluation of gene expression data is a challenging
task due to statistical as well as interpretational pitfalls.
Due to the complexity of the cellular networks the inter-
action between the different components is not known,
and therefore a basic assumption of parametric hypoth-
esis testing namely that the variables are independent
and identical distributed is not met. The large number
of features to be assessed per sample demands multiple
testing corrections to minimize the number of false
positives. Furthermore the often low sample number
leads to inaccurate estimations of statistical parameters
(e.g. the within group variability for a linear model or
the mean value for fold-change calculation). As a conse-
quence, the strategy of judging the biological relevance
of a single transcript solely based on its fold-change or
significant p-value is pronet ob eh a m p e r e db yr a n d o m
effects.
The advent of biological databases governing a rapidly
growing pool of gene annotation data permits to set
gene expression profiles in a global biological context
and thus putting newly drawn hypothesis on a more
solid foundation.
In our work the relevance of our findings was opti-
mized by the consideration of the following aspects.
Due to the limited number of samples i.e. 3 animals per
time point and tissue, the control of sample variability is
crucial. As the main sources of variability we defined
variations in the occurrence and extent of the disease-
induced brain damage and the quality of the microarray
probe generation. Standardization of brain damage was
achieved by selecting animals with a similar score of
apoptotic cells in the hippocampal dentate gyrus.
Experimental in vivo models of infection inherently
show a variability in clinical severity of disease and the
corresponding disease parameters e.g. pathogen burden,
inflammatory cyto-/and chemokines, and tissue destruc-
tion. Inter-individual variability in disease and the subse-
quent readouts (i.e. apoptosis) occurs also in the present
experimental model of BM. Therefore we regard this
kind of standardisation as mandatory also with larger
sample groups to avoid an increase in gene expression
variability, which may hamper the detection of minor
but still biological significant expressional changes. RNA
quality was assessed prior and after chip hybridization.
After background correction and normalization of the
raw data using a non-linear and robust multi array
approach, the structure of the expression data was
investigated by Correspondence Analysis (COA). The
COA analysis revealed that all samples were separated
correctly in regard to infection, sampling time and tissue
type based on the inherent structure of the expression
data. This finding indicates that there are substantial dif-
ferences in the regulation of the transcriptome in regard
to sampling time and sample origin, and demonstrates
that the within-group-variability was sufficiently low to
allow the separation of the groups (Figure 3).
After these pre-considerations, significance testing was
performed with a moderated Bayesian t-statistics com-
paring each sample of the infected animals with the
according age matched uninfected controls. Using age
match controls is mandatory in order to eliminate genes
that are differently expressed due to brain developmen-
tal processes, which may be ongoing in the experimental
infant rat model used.
A further issue that has to be addressed in cerebral
gene expression analysis is the complexity of the
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Page 13 of 21Figure 8 Histomorphometry of microglia response. The picture sequence demonstrates the morphological and spatial changes of microglia
in response to experimental bacterial meningitis due to infection with S .pneumoniae. Microglial staining was performed by staining AIF-1 and
sections were observed using a 20 × (pictures A, C and E), respectively 40 × (pictures B, D and F) magnifying objective. The resting microglia
(picture A and B) transforms from a ramified to an amoeboid, phagocytic phenotype during the early acute phase of the disease (pictures C and
D). Three days after infection we find a pronounced infiltration of microglial cells into the subgranular zone of the dentate gyrus (highlighted by
dotted lines) where neuronal apoptosis occurs (picture E and F). The transformation and redistribution of the resting microglia to the site of
tissue damage is in well agreement with the transcriptional data shown in figure 9.
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Page 14 of 21samples in regard to the different cell types within a
given brain structure. This implies that the expressional
pattern obtained from a given experimental condition is
an overlay collage of various transcriptomic profiles
from different cell populations. As a consequence the
expressional level of a transcript depends on the extent
of transcriptional regulation and the proportion of cells
expressing the transcript. Therefore significant
expressional changes in genes expressed only in a small
fraction of cells may be diluted by the expressional
“noise” by cells of the surrounding tissue. Furthermore
reciprocal gene regulation in two cell populations can
lead to an underestimation of real changes. Under this
consideration the assignment of expressional changes to
the evoking cell population is crucial for data
interpretation.
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Figure 9 Regulation of microglial response. Expression kinetics of genes, involved in microglia regulation, in response to pneumococcal
infection. A) Components of the Toll-like receptor pathway initiating the innate immune response, pro-inflammatory mediators and microglial
“On” signals show their expression maxima in the acute phase of the disease at 1 day post infection (hpi). B) At 3 days after infection we find an
expressional peak of transcripts coding for receptors that guide the resting microglia to the site of action and which orchestrate phagocytic and
trophic functions during tissue regeneration. Furthermore there is a transcriptional peak of factors expressed in activated microglia which lead to
a down-modulation of the immune response.
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Page 15 of 21In our study we focused on the events that take place
in the acute and regenerative phase of bacterial menin-
gitis in two distinct brain structures, namely the cortex
and the hippocampus. In order to bring expressional
data into a cell morphological context, we assessed the
presence and distribution of microglia and that of prolif-
erating cells in the hippocampus. These two cell popula-
tions play a pivotal role in the two disease phases
investigated. There is growing evidence that the micro-
glia takes the directorial role in coordinating the inflam-
matory response in the central nervous system (CNS)
due to its capability to rapidly release autocrine and
paracrine factors. Upon infection the microglia initiates
a robust innate immune response in the immune-privi-
leged brain tissue and is involved in the clean up of
dying cells by the differentiation into a macrophage phe-
notype. Recent studies showed a strong correlation
between the microglia activation induced by the patho-
gen and the modulation of hippocampal neurogenesis.
Furthermore there is evidence, that the mode of micro-
glia activation is an important determinant of neurogen-
esis and neuronal survival [22,23,33]. Whereas
endotoxin activation leads to an impairment of neuro-
genesis and oligodendrogenesis, microglia activation by
an adaptive immune response supports neuronal survi-
val [36]. The interpretation of the expressional data in
the following part of the discussion will be set in the
light of the interaction between the activated microglia
and the proliferating neuronal progenitor cells.
Regulation of the host defence: Tissue and time
Intersection
In the acute phase of the disease the genes that were
found to be significantly expressed in both tissues were
almost exclusively involved in processes of the immune-
and inflammatory response. Many transcripts found to
be regulated in the processes of the host defence have a
function in the activation and propagation of the innate
immunity response, the main defence system in the
otherwise immune-privileged brain tissue.
The up-regulation of genes coding for pattern recogni-
tion receptors specific for Gram-positive bacteria (TLR2,
CD14) expressed on astrocytes, oligodendrocytes and
microglia indicates the recognition of invading S.pneu-
moniae by resident cells of the CNS. The concomitant
up-regulation of several components of the Toll-like sig-
nalling pathway (MyD88, I-kappaB, NF-kappaB, AP-1)
induces the expression of pro-inflammatory cytokines
and components of the complement system triggering
the activation of glial cells [17,34-38].
Glial activation is reflected by the up-regulation of cell
type specific markers as there are allograft inflammatory
factor 1 (AIF-1) and CD68 for microglia and glial fibril-
lary acidic protein (GFAP) specific for astrocytes. The
induction of astrocyte activation is also reflected by an
up-regulation of BMP-2, STAT3 and p300 which are
factors in the BMP signalling pathway. Upon BMP bind-
ing to its receptor Smad1 is phosphorylated and
migrates to the nucleus. There it forms a transcriptional
complex with STAT3 and the co-activator p300 on the
promoter sequence of the astrocyte-specific genes such
as the one for the glial fibrillary acidic protein (GFAP)
thereby inducing astrocyte activation [37-40]. The tran-
scription level of the oligodendrocytes marker cyclic
nucleotide phosphodiesterase 1 (CNP-1) was unaltered
suggesting a limited role of this cell population in the
initiation of host defence.
The activation of the microglia is also evident based
on the immunohistochemical detection of AIF-1 protein
in the course of the disease which shows the emergence
of rod shaped amoeboid cells from the resting popula-
tion expressing a more ramified phenotype (Figure 8).
There is ample evidence from experimental studies, that
the activation of astrocytes and microglia has a pro-
nounced impact on the surrounding neuronal tissue as
for example the induction of blood brain barrier disrup-
tion, vasculitis and apoptotic as well as necrotic cell
death. In PM microglia are considered to form a first
line of defence against invading bacteria and play a role
in the regulation of the inflammatory reaction in
response to infection. Extensive microglial activation has
been shown to contribute to tissue damage in PM
[16,18]. In previous studies we used immunohistochem-
istry and histomorphology to document an increase in
microglia activation with disease progression in PM
[15,19]. Correspondingly, microglial activation has been
demonstrated in a rat model of ischemic brain injury
[41].
The over-representation of biological processes
involved in cell death and blood vessel morphogenesis
and the localization of theses events to the proteinac-
eous extracellular matrix reflects these events in our
expressional data. The evaluation of these processes on
gene level reveals a high accordance with the findings of
us and others in the field of bacterial meningitis thus
validating our experimental approach [38,42-46]. In
addition to the confirmation of recent data, we found
new aspects concerning the modulation of microglial
activity by surrounding neurons that to our knowledge
have not yet been reported for bacterial meningitis. Tra-
ditionally microglia activation was regarded as a stereo-
typic and graded process with devastating consequences
for the surrounding neurons. Recent findings indicate
that microglial cells are able to integrate various inputs
from the surrounding milieu and thereby tune their
response appropriately. Microglia activation in the
healthy brain is controlled by “On” and “Off” signals
[37]. “Off” signals are constitutively expressed in the
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tion [40]. In contrast “On” signals are produced on
demand to initiate a pro- or anti-inflammatory micro-
glial response [39]. According to their occurrence “On”
and “Off” signals are separated into a released or a
membrane bound fraction. Our data show that conco-
mitantly with the up-regulation of the microglia asso-
ciated transcripts (CD68 and AIF-1), the released “On”
signals matrix-metalloproteinase-3 (MMP-3) and
CXCL10 are up-regulated in the acute phase (1 day
after infection) of the disease, whereas the released “Off”
signal CX3CL1 is down-regulated. In vitro studies have
s h o w nt h a tC X C L 1 0i ss e c r e t e db ye n d a n g e r e dn e u r o n s
and directs microglia migration by binding to the micro-
glial CXC3 receptor.
The release of MMP-3 was also attributed to neuronal
cell degradation. Previous studies [47] showed that
besides its involvement in the disruption of the blood
brain barrier, MMP-3 is released by apoptotic neuronal
cell lines and mediates the discharge of cytokines of
contiguous microglial cells. Thus it has been hypothe-
sized that MMP-3 signalling may trigger inflammatory
reactions as well as a rapid phagocytosis of apoptotic
neurons.
With the progression of the disease into the late phase
(3 days after infection) the up-regulation of the marker
CD68 reflects microglial differentiation into a macro-
phagic phenotype. This finding is also reflected by our
immunohistochemical data where we see a further
increase in the number of rod shaped amoeboid micro-
glial cells. The transition of microglial function from
triggering the innate immune response to the phagocytic
clearance of cellular debris and inflammatory control is
also reflected in the type of microglial regulators. In our
data we found the up-regulation of microglial receptors
activated by pro-phagocytotic “eat me” signals and tran-
scripts which function as immune silencers.
The metabotropic P2-purinoreceptor P2Y12 is stimu-
lated by ATP released by injured neurons and thereby
guides the microglial cells to areas of tissue damage
[48,49]. TREM2, a further microglial receptor found to
be up-regulated is involved in the modulation of inflam-
mation and phagocytosis. Knockdown of TREM2 in
mice inhibited phagocytosis of apoptotic neurons and
increased gene transcription of pro- inflammatory genes
[50-52]. Although pointing to a down-regulation of
inflammation is the enhanced expression of CD68 a
member of the family of neuroimmune regulatory pro-
teins (NIRegs). These proteins may play an important
role in controlling lymphocyte/macrophage/microglia
hyperinflammatory responses, while sparing host
defence and repair mechanisms. Moreover, NIRegs have
direct beneficial effects on neurogenesis and are contri-
buting to brain tissue remodelling [53].
Regenerative phase of the disease
W h i l ei nt h ea c u t ep h a s eo ft h ed i s e a s e( 1d a ya f t e r
infection) similar GO terms were over-represented in
the hippocampal and the cortical set of regulated genes,
the results of GO statistics in the late acute phase (3
days after infection) diverge. Whereas in the cortex pro-
cesses of synaptic transmission were over-represented,
GO terms associated with gene regulation at 3 days
after infection in the hippocampus are pointing to pro-
cesses of neurogenesis and neuronal migration. KEGG
pathway analysis revealed an activation of the TGF-b
and wnt signalling pathway, two pathways known to
play a central role in different aspects of cell
development.
The wnt signalling pathway is known to participate in
several aspects of neural development including stem
cell proliferation and maintenance, fate determination,
axon guidance, dendrite development and synapse for-
mation [54]. Upon binding of a member of the wnt
family to the corresponding receptor two distinct path-
ways can be activated. The first pathway is the canonical
branch which activates the b-catenin/TCF transcrip-
tional regulatory complex, and the second one is the
non-canonical branch, which involves a wide range of
downstream signalling effectors.
The influence of the wnt signalling on the target cells
is modulated by a complex regulatory network integrat-
ing various inputs including the level of ligand-receptor
interactions and the diversity of downstream transcrip-
tional complexes. In the adult brain, components of the
canonical wnt signalling pathway were found to be
expressed in both astrocytes and neuronal stem cells in
neurogenic niches e.g. the subgranular zone (SGZ) of
the dentate gyrus. Furthermore, an activation of canoni-
cal wnt/b-catenin/TCF was found in proliferating cells
and a subset of newly generated neurons. Blockade of
wnt signalling reduces the number of proliferating neu-
ronal restricted precursors (NRPs) but had no effect on
the general population of proliferating cells or glia pro-
duction [39].
In the CNS, TGF-b i sk n o w na sa ni n j u r y - r e l a t e d
cytokine produced by astrocytes and neurons [55-57].
The binding of TGF-b to the serine-threonine kinase
receptors TGF-bRI/TGF-bRII activates the transcrip-
tion factors Smad 2/3 and Smad 4. Upon complex for-
mation the Smad 2/3-4 complex translocates to the
nucleus and regulates the response to TGF-b signalling
i.e. cell cycle control, regulation of early development
and differentiation and neuron cell survival [56,58,59].
It has been recognized, that TGF-b secretion by astro-
cytes in the adult brain has a primarily neuroprotective
role. One mode of action is the protection against N-
methyl-D-aspartic acid (NMDA)-induced excitatory
neuronal death by the TGF-b mediated reduction of
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explanation for a neuroprotective effect of TGF-b has
been proposed by TGF-b mediated activation of
nuclear factor- kappaB which in turns exerts an anti-
apoptotic effect on neuronal cells [55].
The cross talk between the wnt- and TGF-b pathway
is mediated by the cooperation between TCF/LEFs and
the SMAD transcription factors that are bound to adja-
cent DNA elements, thereby allowing coordinated regu-
lation of target genes [61,62].
In the present study the up-regulation of key compo-
nents of the wnt- as well as the TGF-b signalling path-
way is accompanied by the emergence of proliferating
BrdU labeled cells in the subgranular zone (SGZ) of the
dentate gyrus. Considering a central role for the canoni-
cal wnt signalling pathway in neuronal proliferation and
fate commitment[39], and acknowledging the fact that
this pathway is exclusively up-regulated in the hippo-
c a m p u si nt h el a t ep h a s eo ft h ed i s e a s e ,w ec o n c l u d e
that the expression of wnt signalling components is
evoked by the population of recently divided cells
(BrdU-labeled) in the SGZ, and that a substantial part of
these cells have a neuronal commitment. This notion is
supported by recent studies [22,23,33,63] assessing neu-
rogenesis in the SGZ after experimental PM which show
that approximately 70% of the BrdU-labeled cells are
positive for the neuronal markers TUC-4, MAP-2 and
beta-tubulin. The, concomitant tissue- and time-specific
activation of both, the wnt-signalling- and the TGF-b
Smad2/Smad3-pathway, is indicative for a synergistic
involvement of both pathways in the fine tuning of neu-
ronal tissue regeneration beyond a merely neuroprotec-
tive function of TGF-b.
Implications for therapeutic strategies
An important finding of the present study is that on a
transcriptional level, the major events with respect to the
regulation of the host response occur within the first 3
days after infection. Beyond this time, there were no
major differences detectable in the gene expression pat-
terns of infected- vs control animals. A strong activation
of neurogenic processes in the hippocampal dentate
gyrus was observed both by gene expression and immu-
nohistochemical labeling of proliferating cells starting as
early as 3 days after infection e. g. during the acute and
sub acute phase of the disease. Thus, there is a therapeu-
tic window of opportunity during the acute phase of bac-
terial meningitis for interventions aimed at supporting
mechanisms of brain regeneration in bacterial meningitis.
Moreover, therapies that potentially impede the
ongoing regenerative processes must be avoided at this
time. In this context our findings add a new viewpoint
to the discussion on the pros and cons of adjunctive
dexamethasone treatment which is recommended to be
initiated before or together with the first dose of anti-
biotic therapy and continued for four days [64]. While
there are studies that demonstrated a beneficial effect of
dexamethasone on the mortality in patients with pneu-
mococcal meningitis, the benefit of the treatment for
the reduction of neurological sequelaes is unproven
[3,8,64,65]. In a more recent study a meta-analysis of
individual patient data from the randomised, double-
blind, placebo-controlled trials of dexamethasone for
bacterial meningitis in patients of all ages for which raw
data were available was performed. After analysis of the
data from 2029 patients from five trials the authors con-
cluded that adjunctive dexamethasone in the treatment
of acute bacterial meningitis does not significantly
reduce death or neurological disability[8]. Furthermore,
there are a number of experimental studies showing
that dexamethasone provokes an increase of apoptotic
cells in the SGZ of the dentate gyrus [31,66,67], which
leads to aggravated learning impairments in PM survi-
vors [31]. In the light of the present data one may spec-
ulate that the observed learning impairments upon
dexamethasone treatment may be due to an impediment
of neurogenic processes in the hippocampus during the
early regenerative phase of the disease. A putative target
for such an impediment is the pro-neurogenic wnt sig-
nalling pathway which we found activated in the hippo-
campus at 3 days after infection. In vitro it has been
shown, that glucocorticoids inhibit wnt signalling by
activating glycogen synthase kinase 3 beta (GSK3b)[68]
by inhibition of the TCF/LEF transcription factor [69]
and by enhancing the expression of Wnt inhibitors
[70-72]. Further emphasis on the importance of the wnt
signalling pathway for hippocampal neurogenesis is pro-
vided by very recent studies showing, that the neuro-
genic effects of antidepressants is most likely effectuated
by an activation of the wnt signal transduction. Wexler
et al [73] showed that the mood stabilizer lithium
enhances the pool of adult hippocampal progenitor cells
and induces a neuronal cell fate. The authors attributed
these effects to a lithium dependent wnt signalling
induction by a down-regulation of GSK3b and an up-
regulation of beta-catenin. In the same line of evidence
it was demonstrated that the chronic administration of
the dual reuptake inhibitor venlafaxine induces the
nuclear translocation of beta-catenin most likely by an
inhibition of GSK3b through AKT/PKB signalling [74].
Based on these findings antidepressants may have the
potential to support hippocampal neuro-regenerative
processes in the recovery phase of pneumococcal
meningitis.
Conclusions
The exponential growth of biological metadata resources
within the last decade advances the analysis of datasets
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mere publication of expansive gene lists to a more
meaningful biological systems based approach.
In this work these metadata resources were used to
identify pivotal gene regulatory events of the animal
host in response to pneumococcal meningitis. Besides
the confirmation of recent findings by other researchers
in the field this work expands the insight in the brains
immunoregulative network as well as in neurogenic
repair mechanisms. Based on the more detailed descrip-
tion of these processes therapeutic schemes can be
developed which balance the benefits of anti-inflamma-
tory drugs in the early phase of the disease and pro-neu-
rogenic agents during regeneration.
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